Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03803696 · ClinicalTrials.gov registry record · NA

Multimodal Sexual Dysfunction Intervention In HCT

A NA study of Hematopoietic Stem Cell Transplantation and Sexual Dysfunction, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
230
Enrollment target
1
Study location

NCT03803696 is a NA study of Hematopoietic Stem Cell Transplantation and Sexual Dysfunction that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 230 participants, below the 9,781-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03803696, a NA study of Hematopoietic Stem Cell Transplantation and Sexual Dysfunction, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
230 participants
Enrollment target
1
Study location

Study Summary

This research study is evaluating the impact of an intervention to improve sexual function in stem cell transplant survivors on participants' sexual function, quality of life, and mood. It is expected that about 120 people who have undergone a stem cell transplant will take part in this research study.

Interventions

  • BEHAVIORAL Enhanced Standard Care
  • BEHAVIORAL Multimodal Intervention to Address Sexual Dysfunction

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2019-02-01
Est. Completion 2025-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03803696

The ClinicalTrials.gov registry entry for NCT03803696 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,781-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (98% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hematopoietic Stem Cell Transplantation appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Standard Care is the first listed.

NCT03803696 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03803696 about?

NCT03803696 is a clinical study titled "Multimodal Sexual Dysfunction Intervention In HCT". This research study is evaluating the impact of an intervention to improve sexual function in stem cell transplant survivors on participants' sexual function, quality of life, and mood. It is expected that about 120 people who have undergone a stem cell transplant will take part in this research st...

What is the current status of trial NCT03803696?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2019-02-01. Estimated completion is 2025-12-31.

What conditions does trial NCT03803696 study?

This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplantation, Sexual Dysfunction, Hematologic Diseases.

What interventions are being tested in trial NCT03803696?

The interventions under investigation include: Enhanced Standard Care (BEHAVIORAL), Multimodal Intervention to Address Sexual Dysfunction (BEHAVIORAL).

Who is sponsoring clinical trial NCT03803696?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03803696 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic Stem Cell Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.